StockSelector.com
  Research, Select, & Monitor Saturday, February 24, 2018 9:05:02 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Revance Therapeutics, Inc.$30.50($.20)(.65%)

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | More...

Your Target?

    Analysts Ratings
Current Summary
Current Rating:Strong Buy (1.25)
Previous Rating:Strong Buy (1.25)
Average Target Price:$42.33
Current Industry Rating:N/A
Previous Industry Rating:N/A

1=Strong Buy

5=Strong Sell
Recent Analysts' Actions
Date Firm Action Rating Previous Target Previous
1/9/2018 H.C. Wainwright & Co., Inc. Established Rating Neutral Buy
12/6/2017 Mizuho Securities Raised Target Price Buy $54.00 $37.00
12/6/2017 Bank of America-Merrill Lynch Established Rating Buy Buy $42.00 N/A
11/27/2017 Barclays Capital Lowered Target Price Buy $31.00 $46.00





Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.